BIOMAT Database Logo BIOMAT Database Logo

[When should antitubercular therapy be administered in Addison's disease?]. 1988

L García Pascual, and A Segura García, and J González Atienza, and J Vilaseca Momplet

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000224 Addison Disease An adrenal disease characterized by the progressive destruction of the ADRENAL CORTEX, resulting in insufficient production of ALDOSTERONE and HYDROCORTISONE. Clinical symptoms include ANOREXIA; NAUSEA; WEIGHT LOSS; MUSCLE WEAKNESS; and HYPERPIGMENTATION of the SKIN due to increase in circulating levels of ACTH precursor hormone which stimulates MELANOCYTES. Addison's Disease,Primary Adrenal Insufficiency,Primary Adrenocortical Insufficiency,Primary Hypoadrenalism,Addisons Disease,Adrenal Insufficiency, Primary,Adrenocortical Insufficiencies, Primary,Adrenocortical Insufficiency, Primary,Disease, Addison,Hypoadrenalism, Primary,Hypoadrenalisms, Primary,Insufficiencies, Primary Adrenocortical,Insufficiency, Primary Adrenocortical,Primary Adrenocortical Insufficiencies
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014401 Tuberculosis, Urogenital A general term for MYCOBACTERIUM infections of any part of the UROGENITAL SYSTEM in either the male or the female. Urogenital Tuberculosis,Tuberculoses, Urogenital,Urogenital Tuberculoses

Related Publications

L García Pascual, and A Segura García, and J González Atienza, and J Vilaseca Momplet
Addison's disease should be diagnosed biochemically.
July 2001, BMJ (Clinical research ed.),
L García Pascual, and A Segura García, and J González Atienza, and J Vilaseca Momplet
[HIV infection: when should zidovudine be administered?].
October 1989, Fortschritte der Medizin,
L García Pascual, and A Segura García, and J González Atienza, and J Vilaseca Momplet
[When should iron be administered orally and when intravenously].
April 1956, Munchener medizinische Wochenschrift (1950),
L García Pascual, and A Segura García, and J González Atienza, and J Vilaseca Momplet
[When must, when should, when can ACE inhibitors be administered in heart failure?].
August 1993, Medizinische Klinik (Munich, Germany : 1983),
L García Pascual, and A Segura García, and J González Atienza, and J Vilaseca Momplet
When Should Therapy for Inflammatory Bowel Disease Be Stopped?
June 2015, Gastroenterology & hepatology,
L García Pascual, and A Segura García, and J González Atienza, and J Vilaseca Momplet
[Addison's disease cured by antitubercular antibiotic therapy. Hormonal study and discussion].
May 1967, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
L García Pascual, and A Segura García, and J González Atienza, and J Vilaseca Momplet
When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?
December 2013, Best practice & research. Clinical haematology,
L García Pascual, and A Segura García, and J González Atienza, and J Vilaseca Momplet
[When should antiretroviral therapy be started?].
August 2001, Praxis,
L García Pascual, and A Segura García, and J González Atienza, and J Vilaseca Momplet
[When should mechanical therapy be instituted?].
September 1976, Revue medicale de la Suisse romande,
L García Pascual, and A Segura García, and J González Atienza, and J Vilaseca Momplet
When should levodopa therapy be initiated in patients with Parkinson's disease?
January 2007, Drugs & aging,
Copied contents to your clipboard!